The role of complement anaphylatoxin receptors in mammary tumour growth: identification of new therapautic targets /

The role of complement anaphylatoxin receptors in mammary tumour growth: identification of new therapautic targets /

Thesis (Ph.D) - The University of Queensland, 2014

Bibliographic Details
Main Authors:	269563 Fazrena Nadia Md. Akhir, The University of Queensland
Format:
Language:	eng
Published:	2014

Similar Items

The role of complement anaphylatoxin receptors in mammary tumour growth: identification of new therapautic targets [electronic resource] /
by: 269563 Fazrena Nadia Md. Akhir, et al.
Published: (2014)

Role of complement anaphylatoxin receptor in cervical cancer growth /
by: Nur Aireena Affeza Muhamad Amran, 1993-, et al.
Published: (2016)

Role of complement anaphylatoxin receptor in cervical cancer growth [electronic resource] /
by: Nur Aireena Affeza Muhamad Amran, 1993-, et al.
Published: (2016)

Antioxidant activity of leaves of M. malabathricum L. (Pink Magenta) [electronic resource] /
by: 269563 Fazrena Nadia Md. Akhir
Published: (2008)

Antioxidant activity of leaves of M. malabathricum L. (Pink Magenta) /
by: 269563 Fazrena Nadia Md. Akhir
Published: (2008)

Development of complement C5a and its receptor in malignant tumour cells as mammary tumour biomarker
by: Ganti, Norhaifa
Published: (2015)

Fibroblast growth factor receptors: their expression and clinicopathological relevance in canine mammary gland tumours
by: Sahabi, Kabiru, et al.
Published: (2014)

Identification and characterization of host miRNAs that target the mouse mammary tumour virus (MMTV) genome
by: Bushra Gull, et al.
Published: (2024-12-01)

An immunoregulatory role for complement receptors in murine models of breast cancer
by: Md Akhir, Fazrena Nadia, et al.
Published: (2021)

Regression mouse mammary tumour through complement-mediated inflammation of C5A/C5AR axis
by: Kamarudin, Nurul Hazwani
Published: (2015)

Expression of proliferating cell nuclear antigen, vimentin and fibroblast growth factor receptors in canine mammary gland tumours as potential markers for tumour growth agressiveness and high grade
by: Sahabi, Kabiru
Published: (2014)

Canine Mammary Mixed Tumours: A Review
by: Geovanni Dantas Cassali, et al.
Published: (2012-01-01)

N-cadherin expression in canine mammary tumours
by: A.K. Anseena, et al.
Published: (2024-03-01)

Histopathological and immunophenotypical classification of canine mammary tumours
by: Nisna Niyas, et al.
Published: (2024-03-01)

Expression and identification of C5a and its receptor (C5aR) as a diagnostic marker for benign mammary tumour
by: Bachek, Noor Farhana
Published: (2016)

Modulation of C5A receptor in mammary gland tumour by EP54 and PMX205 peptides
by: Kosni, Nurneqman Nashreq
Published: (2015)

Feline mammary tumours in western Canada. A retrospective study
by: Abdul Rahman, Sheikh Omar
Published: (1980)

The Effects of Piroxicam and Deracoxib on Canine Mammary Tumour Cell Line
by: Fulya Üstün Alkan, et al.
Published: (2012-01-01)

Epidemiological retrospective studies of feline mammary gland tumours in Bulgaria
by: R. Simeonov, et al.
Published: (2024-12-01)

The effects of meloxicam on the growth and viability of mouse mammary tumour cell lines EMT6 and 4T1
by: Cornelius, Cecilia Evelyn, et al.
Published: (2012)

Effect of dexamethasone on growth and viability of mouse mammary tumour cell lines, EMT6 and 4T1
by: Wan Hassan, Wan Maryani, et al.
Published: (2012)

Mammary gland tumours in the dog, a spontaneous tumour model of comparative value to human breast cancer
by: Sahabi, Kabiru, et al.
Published: (2018)

Unusual Myoid Differentiation in a Canine Benign Mixed Mammary Tumour
by: Barbara Brunetti, et al.
Published: (2021-01-01)

Prognostic markers of canine mammary tumours: Retrospective study of 142 cases
by: M. S. Kovalenko, et al.
Published: (2021-10-01)

Anaphylatoxins orchestrate Th17 response via interactions between CD16+ monocytes and pleural mesothelial cells in tuberculous pleural effusion.
by: Shuanglinzi Deng, et al.
Published: (2021-07-01)

Expression and clinicopathological relevance of Fibroblast Growth Factor Receptors in Canine Mammary Gland Tumors
by: Sahabi, Kabiru, et al.
Published: (2024)

Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells
Published: (2005)

Development and molecular characterization of doxorubicin-resistant canine mammary gland tumour cells
by: Sahabi, Kabiru, et al.
Published: (2022)

Pharmacological correction of the hemostasis system for the surgical treatment of bitches with tumours of the mammary gland
by: D. D. Bely, et al.
Published: (2018-08-01)

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
by: Ye, Xin, et al.
Published: (2018)

Systematic Review: Does Pre-Pubertal Spaying Reduce the Risk of Canine Mammary Tumours?
by: Phillip Guirguis, et al.
Published: (2025-02-01)

Concurrent primary splenic lymphoma and mammary gland tumour with polycystic ovaries in a dog
by: SH Kim, et al.
Published: (2024-02-01)

The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
by: Hande Süer Mickler, et al.
Published: (2024-12-01)

Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1
by: Beach, C, et al.
Published: (2023)

Complement receptors in myeloid cell adhesion and phagocytosis
by: Dustin, M
Published: (2016)

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma.
by: Ananya Roy, et al.
Published: (2016-01-01)

Rationale for targeting complement in COVID‐19
by: Anastasia Polycarpou, et al.
Published: (2020-07-01)

Complement-targeted therapy for autoimmune diseases
by: Chu Cong-Qiu
Published: (2023-12-01)

Effect of Zerumbone-loaded nanostructured lipid carrier on canine mammary gland tumour cell line
by: Foong, Jia Ning
Published: (2015)

Substance P a potent prognostic indicator for canine mammary tumours- a comparative study
by: Soumya Ramankutty, et al.
Published: (2024-10-01)